Otter Simon, Springett Kate, Lucas Kevin, Moore Ann, Horne Rob, Davies Kevin, Young Adam
School of Health Professions, University of Brighton.
J Tissue Viability. 2004 Oct;14(4):137-41. doi: 10.1016/s0965-206x(04)44004-2.
In common with other outcome measures, those for the at-risk rheumatoid foot need to be sensitive, specific and patient focussed, although currently these combined features are not available within one measure. There is also the issue of cross-validation with other commonly used measures to be considered. Both government policy and clinical need predicate development of suitable measures for the rheumatoid foot. In the first part of this paper, general issues relating to outcome measures and some government policy are considered and in the second, outcome measures relating to the at-risk rheumatoid foot are introduced alongside a discussion on the implications for practitioners.
与其他结局指标一样，针对有风险的类风湿性足的指标需要具备敏感性、特异性且以患者为中心，尽管目前尚无一项指标能同时具备这些综合特征。此外，还需考虑与其他常用指标的交叉验证问题。政府政策和临床需求都要求开发适用于类风湿性足的指标。本文第一部分讨论了与结局指标相关的一般问题及一些政府政策，第二部分介绍了与有风险的类风湿性足相关的结局指标，并探讨了其对从业者的影响。
